NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Therapeutic Stories

InnovationPartnershipTherapeutic Gene Therapy Consortium data presented at the European Cystic Fibrosis Conference 2019

InnovationPartnershipTherapeutic Gene Therapy Consortium data presented at the European Cystic Fibrosis Conference 2019

Published on 27th June 2019
PartnershipTherapeutic Genetic ‘switch’ plays role in cancer invasion and drug resistance

PartnershipTherapeutic Genetic ‘switch’ plays role in cancer invasion and drug resistance

Published on 19th June 2019
PreventionTherapeutic Triple hormone combination could hold the key to sustainable weight loss

PreventionTherapeutic Triple hormone combination could hold the key to sustainable weight loss

Published on 19th June 2019
Therapeutic Benefits of adjunctive liraglutide treatment after metabolic surgery

Therapeutic Benefits of adjunctive liraglutide treatment after metabolic surgery

Published on 19th June 2019
AwardTherapeutic National recognition for excellence in gastroenterology research

AwardTherapeutic National recognition for excellence in gastroenterology research

Published on 19th June 2019
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Guideline Inequalities in Intensive Care Outcomes for Children Highlighted in New Study
  • Prevention Study uncovers the positive aspects of weight loss in human fat tissue
  • Appointment The UK DRI Centre for Care Research & Technology announced new leader
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre